高级搜索

静脉注射岩舒合并介入治疗原发性肝癌的82例随机对照研究

李柱, 陈晓秋, 李亮, 童刚领, 彭安

李柱, 陈晓秋, 李亮, 童刚领, 彭安. 静脉注射岩舒合并介入治疗原发性肝癌的82例随机对照研究[J]. 肿瘤防治研究, 2012, 39(07): 844-846. DOI: 10.3971/j.issn.1000-8578.2012.07.020
引用本文: 李柱, 陈晓秋, 李亮, 童刚领, 彭安. 静脉注射岩舒合并介入治疗原发性肝癌的82例随机对照研究[J]. 肿瘤防治研究, 2012, 39(07): 844-846. DOI: 10.3971/j.issn.1000-8578.2012.07.020
Li Zhu, Chen Xiaoqiu, Li Liang, Tong Gangling, Peng An. Clinical Effects of Yanshu on Primary Hepatic Carcinoma Treated with Interventional Therapy[J]. Cancer Research on Prevention and Treatment, 2012, 39(07): 844-846. DOI: 10.3971/j.issn.1000-8578.2012.07.020
Citation: Li Zhu, Chen Xiaoqiu, Li Liang, Tong Gangling, Peng An. Clinical Effects of Yanshu on Primary Hepatic Carcinoma Treated with Interventional Therapy[J]. Cancer Research on Prevention and Treatment, 2012, 39(07): 844-846. DOI: 10.3971/j.issn.1000-8578.2012.07.020

静脉注射岩舒合并介入治疗原发性肝癌的82例随机对照研究

详细信息
    作者简介:

    李柱(1979-),男,本科,主治医师,主要从事肿瘤内科工作

    通信作者:

    彭安,E-mail:shenzhen-pengan@126.com

  • 中图分类号: R737.7

Clinical Effects of Yanshu on Primary Hepatic Carcinoma Treated with Interventional Therapy

  • 摘要: 目的 探讨岩舒在肝动脉插管化疗栓塞术治疗原发性肝癌的辅助治疗效果。方法选择需实施肝动脉插管治疗的原发性肝癌患者82名,随机分成治疗组42名,对照组40名。治疗组在肝动脉插管化疗栓塞术全程给予岩舒静脉滴注,对照组仅实施肝动脉插管化疗栓塞。比较两组治疗效果、生存率、临床症状及不良反应。结果治疗组和对照组总有效率比较差异无统计学意义。治疗组的24月生存率明显高于对照组(P<0.05)。治疗后治疗组患者肝区疼痛、腹胀、乏力、发热等临床症状较对照组有较大缓解(P<0.05)。治疗组患者骨髓抑制发生率比对照组明显降低(P<0.05),且对肝功能具有明显的保护作用。结论肝动脉插管化疗栓塞术中静脉注射岩舒,可保护肝功能、改善患者的临床症状、降低不良反应。

     

    Abstract: Objective To study the clinical effect of Yanshu on primary hepatic carcinoma treated with interventional therapy. Methods A total of 82 patients with primary hepatic carcinoma were randomly divided into the treatment group(42 cases) and control group(40 cases). All patients concurrently received TACE,and the treatment group was additionally treated with Yanshu injection. The curative effects, survival period, clinical symptoms and toxic reactions were observed. Results There was no significant difference between two groups in total effective rates(P<0.05). However, there were significant differences in 24-months-survival-rates, clinical symptoms and toxic reactions between two groups(P<0.05). Conclusion TACE in combination with Yanshu can protect liver function, improve clinical symptoms, reduce toxic effects and prolong survival of patients.

     

  • [1] Gao QY.Comparison of Lipiodol Chemoembolization and Conservative Treatment for Unresectable HepatocellularCarcinoma[J].Guo Wai Yi Xue(Zhong Liu Xue Fen Ce),1995,22(5):313.[高庆云.化疗栓塞与保守治疗肝癌的前瞻性对照研究[J].国外医学(肿瘤学分册),1995,22(5):313.]
    [2] Chen XM, Luo PF,Hu JL,et al.Delayed adverse reaction of liver after lopiodol-transcathetr arterialcheoembolizetion for the treatment of hepatocellular carcinoma[J].Ai Zheng,1994,13(1):50-3.[陈晓明,罗鹏飞,胡景玲,等.肝癌经导管肝动脉碘油抗癌药混悬剂栓塞后肝脏的延期不良反应[J].癌症,1994,13(1):50-3.]
    [3] Tao Q.Quality of life and analgesic effect of Compound Kushen injection in advanced cancer[J].Zhongguo ZhongYi Ji Zheng,2002,11(1):62-3.[陶强.复方苦参注射液对晚期肿瘤患者生存质量与镇痛作用观察[J].中国中医急症,2002,11(1):62-3.]
    [4] Yang J,Wang TF.Observation of Yanshu injection treatment of various cancer pain[J].Guiyang Zhong Yi Xue YuanXue Bao,2000,22(4):19.[杨洁,王天凤.岩舒注射液治疗各种癌性疼痛的观察体会[J].贵阳中医学院学报,2000,22(4):19.]
    [5] Xuan LJ.Observation on Attenuation of Compound Kushen injection for chemotherapy[J]. Shi Yong Zhong Yi Nei KeZa Zhi,2005,19(3):275.[宣丽君.复方苦参注射液对化疗减毒作用的临床观察[J].实用中医内科杂志,2005,19(3):275.]
    [6] Zhang LH,Chen BE,Pan MJ.Progress in studies on pharmacological effect of Matrine[J]. Zhong Cao Yao,2009,40(6):1000-3.[张丽华,陈邦恩,潘明佳.苦参碱药理作用研究进展[J].中草药,2009,40(6):1000-3.]
    [7] Li N,Gao Y,Li HX.Histopathological Effects of matrine on rats with chronic alcoholic liver injury[J].Bei FangYao Xue,2011,8(1):65-8.[李南,高艳,李海讯.苦参碱对大鼠慢性酒精性肝损伤组织病理学影响的研究[J].北方药学,2011,8(1):65-8.]
    [8] Sun ZD,Zhang CX.Combination traditional chinese medicine with intra-hepatic-arterial chenotherapy treantment on 85 cases ofadvanced hepatic carcinoma[J].Shi Yong Zhong Xi Yi Jie He Za Zhi,1997,10(7):616.[孙在典,张才兴.肝动脉介入化疗结合中药治疗中晚期原发性肝癌85例[J].实用中西医结合杂志,1997,10(7):616.]
    [9] Ota Hideo.Current Interventional Radiology[J].Lin Chuang Wai Ke,1987,42(15):1623.[大田日出夫.介入放射学现状[J].临床外科,1987,42(15):1623.]
    [10] Zhang AM,Wang WM,Wu JJ.Effect of yanshu on primary hepatic carcinoma treated with interventional therapy[J].Zhongguo Yi Yuan Yong Yao Ping Jia Yu Fen Xi, 2006,6(6):373-5.[张爱民,王宛明,吴菁菁.岩舒对原发性肝癌介入治疗的影响[J].中国医院用药评价与分析,2006,6(6):373-5.]
计量
  • 文章访问数:  2320
  • HTML全文浏览量:  30
  • PDF下载量:  610
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-01-17
  • 修回日期:  2012-05-20
  • 刊出日期:  2012-07-24

目录

    /

    返回文章
    返回